Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2003
09/04/2003WO2003014151A3 Human secreted proteins, their encoding polynucleotides, and uses thereof
09/04/2003WO2003001212A3 A method for diagnosing a person having multiple sclerosis
09/04/2003WO2002103016A3 Human tachykinin-related splice variants and compositions thereof
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
09/04/2003WO2002101044A3 Brain expressed gene and protein associated with bipolar disorder
09/04/2003WO2002097395A3 P-cadherin as a target for anti-cancer therapy
09/04/2003WO2002083858A8 Methods to inhibit viral replication
09/04/2003WO2002083853A3 Method for enhancing the translation and expression of recombinant proteins
09/04/2003WO2002078600A3 γεRACK PEPTIDE COMPOSITION AND METHOD FOR PROTECTION AGAINST TISSUE DAMAGE DUE TO ISCHEMIA
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation
09/04/2003WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression
09/04/2003WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
09/04/2003WO2002046237A3 Humanized antibodies that recognize beta amyloid peptide
09/04/2003WO2002036807A3 Compositions and methods relating to breast specific genes and proteins
09/04/2003WO2002032943A9 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
09/04/2003WO2002022667A3 Twin-arginine translocation in bacillus
09/04/2003WO2001066595A9 Human fgf-23 gene and gene expression products
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003US20030167520 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins
09/04/2003US20030167502 Human monoclonal antibodies to dendritic cells
09/04/2003US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences
09/04/2003US20030167489 For transgenic mice that produce high levels of humanizing antibodies; immunoglobulins
09/04/2003US20030166915 Retrovirus from the HIV group and its use
09/04/2003US20030166911 Hybrid nucleic acids; genetic engineering
09/04/2003US20030166910 Bone morphogenic protein
09/04/2003US20030166905 Mutant luciferases
09/04/2003US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders
09/04/2003US20030166883 Genetic engineering; drug screening
09/04/2003US20030166876 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3
09/04/2003US20030166875 Fibroblast growth factor homologous factor-2 and methods of use
09/04/2003US20030166873 Endothelial growth factor; measuring binding to monoclonal antibodies; calibration
09/04/2003US20030166871 Grafting; forming libraries; anticancer agents
09/04/2003US20030166869 Chromatography separation using apatite
09/04/2003US20030166868 Detecting binding; measurement; calibration
09/04/2003US20030166862 Purified mammalian CTLA-8 antigens and related reagents
09/04/2003US20030166861 Human blue-light photoreceptor hCRY2
09/04/2003US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents
09/04/2003US20030166857 Genes for receptor tyrosine kinases and their cognate ligands, their insertion into genetic engineered DNA vectors; useful in the diagnosis and treatment of neoplastic diseases
09/04/2003US20030166854 Allelic variant of human STAT3
09/04/2003US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound
09/04/2003US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
09/04/2003US20030166848 Polypeptides having specific amino acid sequence lacking its associated signal peptide; a chimeric polypeptide fused to a heterologous polypeptide which is an epitope tag or an Fc region of an immunoglobulin
09/04/2003US20030166846 Self-aligning peptides modeled on human elastin and other fibrous proteins
09/04/2003US20030166844 Immunologenic polypeptides; therapy for Streptococcus infections
09/04/2003US20030166838 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives
09/04/2003US20030166832 Methods and compositions for impairing multiplication of HIV-1
09/04/2003US20030166589 Method and pharmaceutical composition for the treatment of multiple sclerosis
09/04/2003US20030166587 Compounds and methods for modulating activation of NF-kB
09/04/2003US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions
09/04/2003US20030166551 For inhibiting expression of adhesion molecules in vascular endothelial cells comprising adipose tissue-specific secretory factor
09/04/2003US20030166543 Functional antagonists of hedgehog activity
09/04/2003US20030166540 Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY30
09/04/2003US20030166536 Expression product of DNA encoding human or hybrid human/ mammalian factor VIII, said DNA comprising DNA encoding a modified A2 domain, the DNA having one or more nucleotide substitutions resulting in a coding change at one or more of
09/04/2003US20030166532 Annexin V, is used to prevent thrombosis without increasing hemorrhage. Annexin binds to phosphatidylserine on the outer surface of cell membranes, thereby preventing binding of the prothrombinase complex necessary for thrombus formation.
09/04/2003US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
09/04/2003US20030166504 Therapeutic compositions and methods for treating viral infection
09/04/2003US20030166300 Growth-related inflammatory and immune response protein
09/04/2003US20030166279 Minicell-based transfection
09/04/2003US20030166275 Preparation of erythropoietin by endogenous gene activation
09/04/2003US20030166247 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures
09/04/2003US20030166242 25828, a novel human aminopeptidase and uses therefor
09/04/2003US20030166240 DNA & protein binding miniature proteins
09/04/2003US20030166239 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques
09/04/2003US20030166238 Recombinant toxin fragments
09/04/2003US20030166228 Anti-interferon-alpha antibodies
09/04/2003US20030166210 Polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for the treatment of cognitive and
09/04/2003US20030166194 Of given sequence; genetic mapping; anticoagulants
09/04/2003US20030166193 Suppressors of death domains
09/04/2003US20030166164 IL-17 like molecules and uses thereof
09/04/2003US20030166162 Preparing genetically engineered polypeptides/zymogens for pharmaceutical or food composition
09/04/2003US20030166155 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/04/2003US20030166154 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
09/04/2003US20030166151 Comprises peptides of ionotropic glutamate receptor for diagnosing and treating nervous system disorders; drug screening
09/04/2003US20030166150 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
09/04/2003US20030166149 Using propyl transferase to generate hydroxylated fibrous protein for cosmetic surgery, tissue engineering and wound treatment
09/04/2003US20030166146 Genetically engineered tissue for treating neurodegenerative diseases and bovine spongiform encephalopathy (BSE)
09/04/2003US20030166141 Regulation of endogenous gene expression in cells using zinc finger proteins
09/04/2003US20030166132 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166116 Nucleotide sequences for the control of the expression of DNA sequences in a cell host
09/04/2003US20030166102 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166101 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166100 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166099 Micelles comprising transmembrane polypeptides and expression vectors for use as drug screeening, gene transfer and diagnostic tools
09/04/2003US20030166098 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166097 Comprises nucleotide sequences coding membrane proteins for use diagnosing, treating and preventing autoimmune, inflammatory, viral, infectious and cancer diseases
09/04/2003US20030166096 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166095 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166094 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166093 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166092 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166091 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166090 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166089 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166088 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166087 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166086 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166085 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166084 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166083 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 ... 1125